149 related articles for article (PubMed ID: 7594352)
1. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth.
Nakajima N; Kuwayama H; Iwasaki A; Arakawa Y
J Clin Gastroenterol; 1995; 20 Suppl 2():S90-2. PubMed ID: 7594352
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
Nakao M; Malfertheiner P
Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
[TBL] [Abstract][Full Text] [Related]
3. Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori.
Suzuki M; Nakamura M; Mori M; Miura S; Tsuchiya M; Ishii H
J Clin Gastroenterol; 1995; 20 Suppl 2():S93-6. PubMed ID: 7594353
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
Nakao M; Tada M; Tsuchimori K; Uekata M
Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):391-9. PubMed ID: 7556227
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.
Berstad AE; Hatlebakk JG; Maartmann-Moe H; Berstad A; Brandtzaeg P
Gut; 1997 Dec; 41(6):740-7. PubMed ID: 9462205
[TBL] [Abstract][Full Text] [Related]
6. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
[TBL] [Abstract][Full Text] [Related]
7. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
Ogoshi K; Kato T; Sakagawa T
J Clin Gastroenterol; 1995; 20 Suppl 2():S97-9. PubMed ID: 7594354
[TBL] [Abstract][Full Text] [Related]
8. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.
Nagata K; Sone N; Tamura T
Antimicrob Agents Chemother; 2001 May; 45(5):1522-7. PubMed ID: 11302821
[TBL] [Abstract][Full Text] [Related]
10. Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori.
Furuta T; Futami H; Arai H; Hanai H; Kaneko E
J Clin Gastroenterol; 1995; 20 Suppl 2():S107-11. PubMed ID: 7594323
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.
Iwahi T; Satoh H; Nakao M; Iwasaki T; Yamazaki T; Kubo K; Tamura T; Imada A
Antimicrob Agents Chemother; 1991 Mar; 35(3):490-6. PubMed ID: 2039199
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
[No Abstract] [Full Text] [Related]
14. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
15. Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection.
Hazell SL; Mitchell HM; Hanna G; Daskalopoulos G
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):530-2. PubMed ID: 9272389
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
Nakao M
J Clin Gastroenterol; 1995; 20 Suppl 1():S32-7. PubMed ID: 7673612
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
Dattilo M; Figura N
J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
[TBL] [Abstract][Full Text] [Related]
19. The effect of lansoprazole treatment on the healing and relapse of peptic ulcer and serum levels of IgG anti-Helicobacter pylori antibody.
Mine T; Yasuda H; Akimoto K; Katoaka A; Mashima H; Tajima A; Fukujin H; Tsuchida T; Takano T; Nagasawa J
J Clin Gastroenterol; 1995; 20 Suppl 2():S75-8. PubMed ID: 7594347
[TBL] [Abstract][Full Text] [Related]
20. Uptake site of lansoprazole, a proton pump inhibitor, in human fundic mucosa: possible relevance with fibroblast and Helicobacter pylori.
Nakamura M; Oda M; Akiba Y; Inoue J; Ito T; Fujiwara T; Tsuchiya M; Ishii H
Cell Mol Biol (Noisy-le-grand); 1995 Feb; 41(1):125-30. PubMed ID: 7773126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]